This content is provided by Cheryl Reicin.
Cheryl is the practice leader of Torys’ Life Science Group, a cross-border group in both Canada and New York. Cheryl represents the whole spectrum of biotech, medical device and health technology companies, from start-ups to large public companies, as well as venture capitalists, investment banks and academic medical centers. She advises companies, in joint ventures and licensing transactions, financing and mergers and acquisitions throughout the world.
Total 4 Articles, Highlights and Press Releases